The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease
Diagnostics · 06.01.2025 · 15 (1) · 113
DOI: 10.3390/diagnostics15010113 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 06.01.2025. Verfasst von Angeliki Mouzarou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Paphos General Hospital, State Health Organization Services, Paphos 8026, Cyprus. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypertension is a major risk factor of various cardiac complications, including hypertensive heart disease (HHD). This condition can lead to a number of structural and functional changes in the heart, such as left ventricular hypertrophy, diastolic dysfunction, and, eventually, systolic dysfunction. In the management of hypertensive heart disease, early diagnosis and appropriate treatment are crucial for preventing the progression to congestive heart failure. One potential diagnostic marker that has gained attention in recent years is the N-terminal pro-brain natriuretic peptide (NT-proBNP). The natriuretic peptides, including the brain natriuretic peptide (BNP) and its inactive N-terminal fragment, are secreted by the myocardium in response to increased wall stress and volume overload. In patients with hypertensive heart disease, increased NT-proBNP levels may reflect the structural and functional changes occurring in the myocardium as a result of chronic pressure overload. Several studies have investigated the diagnostic utility of NT-proBNP in hypertensive heart disease. NT-proBNP levels can be a useful adjunct in the diagnosis of hypertensive heart disease, particularly in the assessment of diastolic dysfunction and left ventricular hypertrophy. This review paper explores the role of NT-proBNP levels in the diagnosis of hypertensive heart disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Paphos General Hospital, State Health Organization Services, Paphos 8026, Cyprus.
ORCID-Profile: Angeliki Mouzarou, Nikoleta Hadjigeorgiou
Zitieren
APA
Mouzarou, A., Hadjigeorgiou, N., Melanarkiti, D., & Plakomyti, T. E. (2025). The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease. Diagnostics, 15(1), 113. https://doi.org/10.3390/diagnostics15010113
Vancouver
Mouzarou A, Hadjigeorgiou N, Melanarkiti D, Plakomyti TE. The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease. Diagnostics. 2025;15(1):113. doi:10.3390/diagnostics15010113
BibTeX
@article{Mouzarou2025,
author = {Mouzarou, Angeliki and Hadjigeorgiou, Nikoleta and Melanarkiti, Despo and Plakomyti, Theodora Eleni},
title = {The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {1},
pages = {113},
doi = {10.3390/diagnostics15010113}
}
EUVIMED